Results

Total Results: 1,540 records

Showing results for "month".

401. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx Source: www.effectivehealthcare.ahrq.gov Published Online: October 7, 2011 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of Angiote…

402. Comparative Effectiveness of Medications in Patients with Epilepsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
     March 01, 2012 - No differences in 12- or 24-month seizure freedom were seen for newer antiepleptic medications versus

403. White Paper_Supplementing Systematic Review Findings With Healthcare System Data: Pilot Projects From the Agency for Healthcare Research and Quality Evidence-based Practice Center Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
     December 01, 2024 - completed systematic review, Management of Infantile Epilepsy,9 which found sparse data on children (age 1 month … referral center in a recent cohort of children/adolescents age <21 (with a subgroup analysis focused on 1-month

404. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
     January 01, 2022 - Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update Evide…

405. The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
     January 01, 2023 - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease Evidence-based Practice Center Systematic Review Protocol Project Title: The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease I. Background and Objectives for the Systematic Review Des…

406. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
     October 01, 2011 - Did the report say whether they actually decreased in those who were still present at month 8? … and 24-month results. … Although the MTA did not use a placebo after the first month, it did have randomized treatment for … At 10-month follow-up after the end of study treatment, the advantage of the systematic medication … The NIMH MTA Follow-up: 24-month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity

407. Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
     January 01, 2014 - Duals had full Medicare and Medicaid coverage (including pre- scription drugs) during the most recent month … Medicaid and participated in the Qualified Medi- care Beneficiary Program during the most recent month … and participated in the Speci- fied Low-Income Medicare Beneficiary Program during the most recent month

408. Treatment Resistant Depression Surveillance FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
     April 01, 2016 - Treatment Resistant Depression Surveillance FINAL AHRQ Systematic Review Surveillance Program CER #33: …

409. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - statistically higher response for the etanercept group compared to MTX, but the primary outcome was at 12 month … Another example is on page 35 at the end of the paragraph labeled 'Rituximab' where again 24 month … ERA: primary outcome was 12 months (pg. 45); IMAGE trial: we modified our text to focus on the 12- month … from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12- month

410. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
     December 20, 2011 - response Criterion E: Duration of disturbance • Duration of disturbance symptoms is more than 1 month … the United States to be 6.8 percent (9.7 percent in women and 3.4 percent in men) and current (12-month … decreased role functioning such as work impairment (on average, 3.6 days of work impairment per month … • Assesses frequency of PTSD symptoms in the past month and self-ratings of impairment across 9

411. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
     June 01, 2017 - Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media …

412. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_june_2012.pdf
     January 01, 2012 - at fewer than 32 weeks gestation) are factors predicting a higher risk of death during the first month … at fewer than 32 weeks’ gestation) are factors predicting a higher risk of death during the first month

413. Osteoporosis-Vibration-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
     January 01, 2020 - Effect of 8-month vertical whole body vibration on bone, muscle performance, and body balance: a randomized … Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control

414. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-F1-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-f1-2.xlsx
     January 01, 2024 - Table F-1. ROB RCTs Table F-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Patient Masked? Care Provider Masked? Outcome Assessors Masked? Intention-To-Treat Analysis? Rate of Overall Attrition Within Acceptable Levels? Rate of Diffe…

415. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
     January 01, 2012 - developmental delays and disabilities is done during regular well-child visits at 9-, 18-, 24- or 30-month … developmental delays and disabilities during well-child pediatrician visits at 9-, 18-, 24- or 30-month … robotic dolls to improve social skills of children with autism child visits at 9-, 18-, 24- or 30-month

416. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - The 2000 study by Davis and colleagues included women who had “…at least a 2- month history of metrorrhagic … For instance had we identified studies of women with light spotting throughout the month, or close … phase” or short cycle where the progestin is administered for (typically) 10-14 days each calendar month … luteal phase, and a long cycle where the progestin is administered for 25 or so days each cycle or month

417. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
     January 01, 2020 - Women were asked about their birth experiences retrospectively (the first interview was 1 month after … The title is Evaluating the Birth Month Breastfeeding Changes to the WIC Food Package?

418. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Patients treated with collaborative care reported more depression-free days during a12-month period … One noncured patient died after 1 month due to toxic megacolon.

419. Executive Summary_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutritional Program for Women, Infants, and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-253-maternal-child-outcomes-wic-executive-summary.pdf
     April 01, 2022 - Executive Summary_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutritional Program for Women, Infants, and Children (WIC) Comparative Effectiveness Review Number 253 Maternal and Child Outcomes Associated With the Special Supplemental Nutritional P…

420. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
     April 01, 2022 - months), and long-term (≥12 months) treatment duration • Studies or outcomes reported with <1 month … Sympathectomy for Sympathetically Maintained Chronic Post-Mastectomy Pain, a Preliminary Report: 6-Month